Longboard Pharmaceuticals, Inc. LBPH NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

42/100

1/6 Pass

SharesGrow Intrinsic Value

共有 50 笔近期内部人交易记录记录，涉及 Longboard Pharmaceuticals, Inc. (LBPH), 包括 33 笔买入 和 15 笔卖出. 内部人买入总额为 $13.74M 内部人卖出总额为 $99.93M.

近期活跃的重要内部人包括 Schneider Phillip M, Sekhri Paul J, Kaye Randall. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — LBPH

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2024-12-02	Schneider Phillip M	Director	股份退回	22,500	$18.94	$426.15K	-
2024-12-02	Sekhri Paul J	Director	股份退回	22,500	$18.94	$426.15K	-
2024-12-02	Kaye Randall	Executive Vice President & CMO	股份退回	9,500	-	-	-
2024-12-02	Roberts Brandi	Executive VP and CFO	股份退回	7,900	-	-	-
2024-12-02	Aurentz Vincent	Director	股份退回	22,500	$18.94	$426.15K	-
2024-12-02	Lind Kevin Robert	President and CEO	股份退回	22,000	-	-	-
2024-12-02	Lynch Casey	Director	股份退回	22,500	$18.94	$426.15K	-
2024-12-02	Le Goff Corinne	Director	股份退回	22,500	$18.94	$426.15K	-
2024-11-19	Kaye Randall	CMO	期权行权	30,554	$6.00	$183.32K	48,474
2024-11-13	Lind Kevin Robert	CEO	期权行权（卖出）	12,808	$3.12	$40K	255,377
2024-10-25	Kaye Randall	CMO	限制性股票授予 (RSU)	9,500	-	-	9,500
2024-10-25	Roberts Brandi	CFO	限制性股票授予 (RSU)	7,900	-	-	7,900
2024-10-25	Lind Kevin Robert	CEO	限制性股票授予 (RSU)	22,000	-	-	22,000
2024-10-15	Kaye Randall	CMO	知情卖出	16,667	$59.04	$983.94K	17,920
2024-09-16	Kaye Randall	CMO	知情卖出	1,900	$34.04	$64.67K	17,920
2024-08-12	Kaye Randall	CMO	知情卖出	6,191	$35.03	$216.86K	17,920
2024-08-12	Lind Kevin Robert	CEO	期权行权（卖出）	2,217	$4.20	$9.31K	192,783
2024-06-25	Kaye Randall	CMO	知情卖出	100	$20.87	$2.09K	-
2024-05-23	Schneider Phillip M	Director	限制性股票授予 (RSU)	22,500	$18.94	$426.15K	22,500
2024-05-23	Sekhri Paul J	Director	限制性股票授予 (RSU)	22,500	$18.94	$426.15K	22,500
2024-05-23	Aurentz Vincent	Director	限制性股票授予 (RSU)	22,500	$18.94	$426.15K	22,500
2024-05-23	Lynch Casey	Director	限制性股票授予 (RSU)	22,500	$18.94	$426.15K	22,500
2024-05-23	Le Goff Corinne	Director	限制性股票授予 (RSU)	22,500	$18.94	$426.15K	22,500
2024-02-08	Kaye Randall	CMO	限制性股票授予 (RSU)	17,920	-	-	17,920
2024-02-08	Roberts Brandi	CFO	限制性股票授予 (RSU)	15,090	-	-	15,090
2024-02-08	Lind Kevin Robert	CEO	限制性股票授予 (RSU)	332,134	$19.32	$6.42M	332,134
2024-01-25	Arena Pharmaceuticals Inc	Other: Former 10% Owner	知情卖出	3,978,540	$24.25	$96.48M	-
2024-01-23	Kaye Randall	CMO	知情买入	100	$24.82	$2.48K	100
2023-05-25	Schneider Phillip M	Director	限制性股票授予 (RSU)	12,500	$7.06	$88.25K	12,500
2023-05-25	Sekhri Paul J	Director	限制性股票授予 (RSU)	12,500	$7.06	$88.25K	12,500
2023-05-25	Aurentz Vincent	Director	限制性股票授予 (RSU)	12,500	$7.06	$88.25K	12,500
2023-05-25	Lynch Casey	Director	限制性股票授予 (RSU)	12,500	$7.06	$88.25K	12,500
2023-05-25	Le Goff Corinne	Director	限制性股票授予 (RSU)	12,500	$7.06	$88.25K	12,500
2023-05-25	Tiller Jane	Director	限制性股票授予 (RSU)	12,500	$7.06	$88.25K	12,500
2023-02-09	Kaye Randall	CMO	限制性股票授予 (RSU)	146,300	$4.35	$636.41K	146,300
2023-02-09	Roberts Brandi	CFO	限制性股票授予 (RSU)	119,700	$4.35	$520.7K	119,700
2023-02-09	Lind Kevin Robert	CEO	限制性股票授予 (RSU)	325,850	$4.35	$1.42M	325,850
2022-05-24	Schneider Phillip M	Director	限制性股票授予 (RSU)	12,367	$4.40	$54.41K	12,367
2022-05-24	Sekhri Paul J	Director	限制性股票授予 (RSU)	12,367	$4.40	$54.41K	12,367
2022-05-24	Aurentz Vincent	Director	限制性股票授予 (RSU)	12,367	$4.40	$54.41K	12,367
2022-05-24	Lynch Casey	Director	限制性股票授予 (RSU)	12,367	$4.40	$54.41K	12,367
2022-05-24	Le Goff Corinne	Director	限制性股票授予 (RSU)	12,367	$4.40	$54.41K	12,367
2022-05-24	Tiller Jane	Director	限制性股票授予 (RSU)	12,367	-	-	12,367
2022-03-21	Kaye Randall	Officer	未知	-	-	-	-
2022-03-21	Kaye Randall	CMO	限制性股票授予 (RSU)	206,500	-	-	206,500
2022-02-09	Roberts Brandi	CFO	限制性股票授予 (RSU)	90,000	$4.20	$378K	90,000
2022-02-09	Lind Kevin Robert	CEO	限制性股票授予 (RSU)	195,000	$4.20	$819K	195,000
2022-02-09	Perera Philip	CMO	限制性股票授予 (RSU)	95,000	$4.20	$399K	95,000
2021-11-15	Tiller Jane	Director	未知	-	-	-	-
2021-11-15	Tiller Jane	Director	限制性股票授予 (RSU)	5,152	$6.21	$31.99K	5,152